Mufson, Elliott J

Grant Detail

The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.

NIA Core Center to Build Neurodegenerative Disease Research Faculty At Penn

Trojanowski, John Q

30 September 2009 - 31 August 2011
NATIONAL INSTITUTE ON AGING
Total Funding: $ 804,917

[unreadable] The University of Pennsylvania (PENN) has strong interdisciplinary research programs on aging related neurodegenerative disorders that develop basic insights Into aging related neurodegenerative disease and Implement programs for developing strategies to prevent or ameliorate Alzheimer's (AD) and Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and front temporal lobar degeneration (FTLD). This P30 Neurodegenerative Disease Core Center will build further the multidisciplinary community of neurodegenerative disease researchers at PENN by recruiting two new faculty whose expertise complements existing programs while adding new content to these programs. This includes a tenure track Neurology faculty with expertise In genomic studies of neurodegenerative diseases and a tenure track experimental Neuropathology faculty with expertise in elucidating contributions of the metabolic syndrome to Increased risk for AD. This will be accomplished through a national search for these faculty as well as mentoring programs and institutional support to seamlessly integrate these new faculty into the PENN neurodegenerative disease research program network. This will lead to new job creation and enhanced capacity to reduce health care costs by improving the care of patients with AD, PD, FTLD, ALS and related disorders. [unreadable] [unreadable] PUBLIC HEALTH RELEVANCE: Completing the Aims of this P30 Neurodegenerative Disease Core Center will build further the multidisciplinary community of neurodegenerative disease researchers at PENN by recruiting two new faculty members whose expertise complements existing PENN programs while adding new content to these programs. This will lead to new job creation and enhanced capacity to reduce health care costs by improving the care of patients with aging related neurodegenerative disorders such as Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration thereby stimulating economic growth. [unreadable] [unreadable] [unreadable] [unreadable]

6 Resulting Publications

• 1.

  2012

  William T Hu; David M Holtzman; Anne M Fagan; Leslie M Shaw; Richard Perrin; Steven E Arnold; Murray Grossman; Chengjie Xiong; Rebecca Craig-Schapiro; Christopher M Clark; et al.

  Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

  Neurology 2012;79(9):897-905.

• 2.

  2010

  J D Rohrer; F Geser; J Zhou; E D Gennatas; M Sidhu; J Q Trojanowski; S J Dearmond; B L Miller; W W Seeley

  TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.

  Neurology 2010;75(24):2204-11.

• 3.

  2010

  W T Hu; A Chen-Plotkin; M Grossman; S E Arnold; C M Clark; L M Shaw; L McCluskey; L Elman; H I Hurtig; A Siderowf; et al.

  Novel CSF biomarkers for frontotemporal lobar degenerations.

  Neurology 2010;75(23):2079-86.

• 4.

  2010

  S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; et al.

  Comparing predictors of conversion and decline in mild cognitive impairment.

  Neurology 2010;75(3):230-8.

• 5.

  2010

  P Vemuri; H J Wiste; S D Weigand; D S Knopman; J Q Trojanowski; L M Shaw; M A Bernstein; P S Aisen; M Weiner; R C Petersen; et al.

  Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

  Neurology 2010;75(2):143-51.

• 6.

  2010

  R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; et al.

  Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

  Neurology 2010;74(3):201-9.

Scientific Context

This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.